| ■ 영문 제목 : Global Narcolepsy Therapeutics Market Growth (Status and Outlook) 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02236 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 87 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦4,941,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,411,500 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦9,882,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 기면증 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (중추 신경계 자극제, 옥시베토나트륨, 선택적 세로토닌 재흡입 억제제 (SSRI), 삼환계 항우울 치료제, 기타)와 용도별 시장규모 (발작성 기면증, 비발작성 기면증, 속발성 기면증) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 기면증 치료제 시장 점유율 - 지역별 기면증 치료제 시장규모 - 주요지역의 종류별 시장규모 (중추 신경계 자극제, 옥시베토나트륨, 선택적 세로토닌 재흡입 억제제 (SSRI), 삼환계 항우울 치료제, 기타) - 주요지역의 용도별 시장규모 (발작성 기면증, 비발작성 기면증, 속발성 기면증) - 미주의 기면증 치료제 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 기면증 치료제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 기면증 치료제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 기면증 치료제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 기면증 치료제 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Addrenex Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Jazz Pharmaceuticals PLC, Graymark Healthcare, Inc., Arena Pharmaceuticals, Inc., BIOPROJET, Takeda, Ligand Pharmaceuticals, Inc. - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Narcolepsy Therapeutics will have significant change from previous year. By the most conservative estimates of global Narcolepsy Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1158.5 million in 2020. Over the next five years the Narcolepsy Therapeutics market will register a 8.1% CAGR in terms of revenue, the global market size will reach US$ 1583.8 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Narcolepsy Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Central nervous system stimulants
Sodium Oxybate
Selective Serotonin Reuptake Inhibitor (SSRI)
Tricyclic Antidepressants
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Narcolepsy With Cataplexy
Narcolepsy Without Cataplexy
Secondary Narcolepsy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Addrenex Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Ltd.
Jazz Pharmaceuticals PLC
Graymark Healthcare, Inc.
Arena Pharmaceuticals, Inc.
BIOPROJET
Takeda
Ligand Pharmaceuticals, Inc.
1 Scope of the Report 2 Executive Summary 3 Narcolepsy Therapeutics Market Size by Players 4 Narcolepsy Therapeutics by Regions 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Global Narcolepsy Therapeutics Market Forecast 11 Key Players Analysis 12 Research Findings and Conclusion List of TablesTable 1. Narcolepsy Therapeutics Market Size CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Central nervous system stimulants Table 3. Major Players of Sodium Oxybate Table 4. Major Players of Selective Serotonin Reuptake Inhibitor (SSRI) Table 5. Major Players of Tricyclic Antidepressants Table 6. Major Players of Others Table 7. Narcolepsy Therapeutics Market Size CAGR by Type (2020-2026) & ($ Millions) Table 8. Global Narcolepsy Therapeutics Market Size by Type (2016-2021) & ($ Millions) Table 9. Global Narcolepsy Therapeutics Market Size Market Share by Type (2016-2021) Table 10. Narcolepsy Therapeutics Market Size CAGR by Application (2016-2021) & ($ Millions) Table 11. Global Narcolepsy Therapeutics Market Size by Application (2016-2021) & ($ Millions) Table 12. Global Narcolepsy Therapeutics Market Size Market Share by Application (2016-2021) Table 13. Global Narcolepsy Therapeutics Revenue by Players (2019-2021E) & ($ Millions) Table 14. Global Narcolepsy Therapeutics Revenue Market Share by Players (2019-2021E) Table 15. Narcolepsy Therapeutics Key Players Head office and Products Offered Table 16. Narcolepsy Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E) Table 17. New Products and Potential Entrants Table 18. Mergers & Acquisitions, Expansion Table 19. Global Narcolepsy Therapeutics Market Size by Regions 2016-2021 & ($ Millions) Table 20. Global Narcolepsy Therapeutics Market Size Market Share by Regions 2016-2021 Table 21. Americas Narcolepsy Therapeutics Market Size by Country (2016-2021) & ($ Millions) Table 22. Americas Narcolepsy Therapeutics Market Size Market Share by Country (2016-2021) Table 23. Americas Narcolepsy Therapeutics Market Size by Type (2016-2021) & ($ Millions) Table 24. Americas Narcolepsy Therapeutics Market Size Market Share by Type (2016-2021) Table 25. Americas Narcolepsy Therapeutics Market Size by Application (2016-2021) & ($ Millions) Table 26. Americas Narcolepsy Therapeutics Market Size Market Share by Application (2016-2021) Table 27. APAC Narcolepsy Therapeutics Market Size by Region (2016-2021) & ($ Millions) Table 28. APAC Narcolepsy Therapeutics Market Size Market Share by Region (2016-2021) Table 29. APAC Narcolepsy Therapeutics Market Size by Type (2016-2021) & ($ Millions) Table 30. APAC Narcolepsy Therapeutics Market Size Market Share by Type (2016-2021) Table 31. APAC Narcolepsy Therapeutics Market Size by Application (2016-2021) & ($ Millions) Table 32. APAC Narcolepsy Therapeutics Market Size Market Share by Application (2016-2021) Table 33. Europe Narcolepsy Therapeutics Market Size by Country (2016-2021) & ($ Millions) Table 34. Europe Narcolepsy Therapeutics Market Size Market Share by Country (2016-2021) Table 35. Europe Narcolepsy Therapeutics Market Size by Type (2016-2021) & ($ Millions) Table 36. Europe Narcolepsy Therapeutics Market Size Market Share by Type (2016-2021) Table 37. Europe Narcolepsy Therapeutics Market Size by Application (2016-2021) & ($ Millions) Table 38. Europe Narcolepsy Therapeutics Market Size Market Share by Application (2016-2021) Table 39. Middle East & Africa Narcolepsy Therapeutics Market Size by Region (2016-2021) & ($ Millions) Table 40. Middle East & Africa Narcolepsy Therapeutics Market Size Market Share by Region (2016-2021) Table 41. Middle East & Africa Narcolepsy Therapeutics Market Size by Type (2016-2021) & ($ Millions) Table 42. Middle East & Africa Narcolepsy Therapeutics Market Size Market Share by Type (2016-2021) Table 43. Middle East & Africa Narcolepsy Therapeutics Market Size by Application (2016-2021) & ($ Millions) Table 44. Middle East & Africa Narcolepsy Therapeutics Market Size Market Share by Application (2016-2021) Table 45. Key and Potential Regions of Narcolepsy Therapeutics Table 46. Key Application and Potential Industries of Narcolepsy Therapeutics Table 47. Key Challenges of Narcolepsy Therapeutics Table 48. Key Trends of Narcolepsy Therapeutics Table 49. Global Narcolepsy Therapeutics Market Size Forecast by Regions (2021-2026) & ($ Millions) Table 50. Global Narcolepsy Therapeutics Market Size Market Share Forecast by Regions (2021-2026) Table 51. Global Narcolepsy Therapeutics Market Size Forecast by Type (2021-2026) & ($ Millions) Table 52. Global Narcolepsy Therapeutics Market Size Market Share Forecast by Type (2021-2026) Table 53. Global Narcolepsy Therapeutics Market Size Forecast by Application (2021-2026) & ($ Millions) Table 54. Global Narcolepsy Therapeutics Market Size Market Share Forecast by Application (2021-2026) Table 55. Addrenex Pharmaceuticals, Inc. Details, Company Type, Narcolepsy Therapeutics Area Served and Its Competitors Table 56. Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Product Offered Table 57. Addrenex Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 58. Addrenex Pharmaceuticals, Inc. Main Business Table 59. Addrenex Pharmaceuticals, Inc. Latest Developments Table 60. Teva Pharmaceutical Industries Ltd. Details, Company Type, Narcolepsy Therapeutics Area Served and Its Competitors Table 61. Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Product Offered Table 62. Teva Pharmaceutical Industries Ltd. Main Business Table 63. Teva Pharmaceutical Industries Ltd. Narcolepsy Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 64. Teva Pharmaceutical Industries Ltd. Latest Developments Table 65. Jazz Pharmaceuticals PLC Details, Company Type, Narcolepsy Therapeutics Area Served and Its Competitors Table 66. Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Product Offered Table 67. Jazz Pharmaceuticals PLC Main Business Table 68. Jazz Pharmaceuticals PLC Narcolepsy Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 69. Jazz Pharmaceuticals PLC Latest Developments Table 70. Graymark Healthcare, Inc. Details, Company Type, Narcolepsy Therapeutics Area Served and Its Competitors Table 71. Graymark Healthcare, Inc. Narcolepsy Therapeutics Product Offered Table 72. Graymark Healthcare, Inc. Main Business Table 73. Graymark Healthcare, Inc. Narcolepsy Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 74. Graymark Healthcare, Inc. Latest Developments Table 75. Arena Pharmaceuticals, Inc. Details, Company Type, Narcolepsy Therapeutics Area Served and Its Competitors Table 76. Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Product Offered Table 77. Arena Pharmaceuticals, Inc. Main Business Table 78. Arena Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 79. Arena Pharmaceuticals, Inc. Latest Developments Table 80. BIOPROJET Details, Company Type, Narcolepsy Therapeutics Area Served and Its Competitors Table 81. BIOPROJET Narcolepsy Therapeutics Product Offered Table 82. BIOPROJET Main Business Table 83. BIOPROJET Narcolepsy Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 84. BIOPROJET Latest Developments Table 85. Takeda Details, Company Type, Narcolepsy Therapeutics Area Served and Its Competitors Table 86. Takeda Narcolepsy Therapeutics Product Offered Table 87. Takeda Main Business Table 88. Takeda Narcolepsy Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 89. Takeda Latest Developments Table 90. Ligand Pharmaceuticals, Inc. Details, Company Type, Narcolepsy Therapeutics Area Served and Its Competitors Table 91. Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Product Offered Table 92. Ligand Pharmaceuticals, Inc. Main Business Table 93. Ligand Pharmaceuticals, Inc. Narcolepsy Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E) Table 94. Ligand Pharmaceuticals, Inc. Latest Developments List of Figures Figure 1. Narcolepsy Therapeutics Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Narcolepsy Therapeutics Market Size Growth Rate 2016-2026 ($ Millions) Figure 6. Global Narcolepsy Therapeutics Market Size Market Share by Type in 2020 Figure 7. Narcolepsy Therapeutics in Narcolepsy With Cataplexy Figure 8. Global Narcolepsy Therapeutics Market: Narcolepsy With Cataplexy (2016-2021) & ($ Millions) Figure 9. Narcolepsy Therapeutics in Narcolepsy Without Cataplexy Figure 10. Global Narcolepsy Therapeutics Market: Narcolepsy Without Cataplexy (2016-2021) & ($ Millions) Figure 11. Narcolepsy Therapeutics in Secondary Narcolepsy Figure 12. Global Narcolepsy Therapeutics Market: Secondary Narcolepsy (2016-2021) & ($ Millions) Figure 13. Global Narcolepsy Therapeutics Market Size Market Share by Application in 2020 Figure 14. Global Narcolepsy Therapeutics Revenue Market Share by Player in 2020 Figure 15. Global Narcolepsy Therapeutics Market Size Market Share by Regions (2016-2021) Figure 16. Americas Narcolepsy Therapeutics Market Size 2016-2021 ($ Millions) Figure 17. APAC Narcolepsy Therapeutics Market Size 2016-2021 ($ Millions) Figure 18. Europe Narcolepsy Therapeutics Market Size 2016-2021 ($ Millions) Figure 19. Middle East & Africa Narcolepsy Therapeutics Market Size 2016-2021 ($ Millions) Figure 20. Americas Narcolepsy Therapeutics Market Size Market Share by Country in 2020 Figure 21. Americas Narcolepsy Therapeutics Market Size Market Share by Type in 2020 Figure 22. Americas Narcolepsy Therapeutics Market Size Market Share by Application in 2020 Figure 23. United States Narcolepsy Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 24. Canada Narcolepsy Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 25. Mexico Narcolepsy Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 26. APAC Narcolepsy Therapeutics Market Size Market Share by Regions in 2020 Figure 27. APAC Narcolepsy Therapeutics Market Size Market Share by Type in 2020 Figure 28. APAC Narcolepsy Therapeutics Market Size Market Share by Application in 2020 Figure 29. China Narcolepsy Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 30. Japan Narcolepsy Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 31. Korea Narcolepsy Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 32. Southeast Asia Narcolepsy Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 33. India Narcolepsy Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 34. Australia Narcolepsy Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 35. Europe Narcolepsy Therapeutics Market Size Market Share by Country in 2020 Figure 36. Europe Narcolepsy Therapeutics Market Size Market Share by Type in 2020 Figure 37. Europe Narcolepsy Therapeutics Market Size Market Share by Application in 2020 Figure 38. Germany Narcolepsy Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 39. France Narcolepsy Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 40. UK Narcolepsy Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 41. Italy Narcolepsy Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 42. Russia Narcolepsy Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 43. Middle East & Africa Narcolepsy Therapeutics Market Size Market Share by Region in 2020 Figure 44. Middle East & Africa Narcolepsy Therapeutics Market Size Market Share by Type in 2020 Figure 45. Middle East & Africa Narcolepsy Therapeutics Market Size Market Share by Application in 2020 Figure 46. Egypt Narcolepsy Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 47. South Africa Narcolepsy Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 48. Israel Narcolepsy Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 49. Turkey Narcolepsy Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 50. GCC Country Narcolepsy Therapeutics Market Size Growth 2016-2021 ($ Millions) Figure 51. Americas Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 52. APAC Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 53. Europe Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 54. Middle East & Africa Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 55. United States Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 56. Canada Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 57. Mexico Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 58. Brazil Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 59. China Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 60. Japan Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 61. Korea Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 62. Southeast Asia Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 63. India Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 64. Australia Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 65. Germany Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 66. France Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 67. UK Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 68. Italy Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 69. Russia Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 70. Spain Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 71. Egypt Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 72. South Africa Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 73. Israel Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 74. Turkey Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) Figure 75. GCC Country Narcolepsy Therapeutics Market Size 2021-2026 ($ Millions) |
| ※본 조사보고서 [세계의 기면증 치료제 시장예측 2021년-2026년] (코드 : LPI-2201K02236) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 기면증 치료제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |